Publication Information

{'id': 'https://openalex.org/W1969041963', 'doi': 'https://doi.org/10.1021/jm060955d', 'title': 'Discovery of ((4<i>R</i>,5<i>S</i>)-5-Amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8<i>H</i>)-yl)methanone (ABT-341), a Highly Potent, Selective, Orally Efficacious, and Safe Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes', 'display_name': 'Discovery of ((4<i>R</i>,5<i>S</i>)-5-Amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8<i>H</i>)-yl)methanone (ABT-341), a Highly Potent, Selective, Orally Efficacious, and Safe Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes', 'publication_year': 2006, 'publication_date': '2006-10-07', 'ids': {'openalex': 'https://openalex.org/W1969041963', 'doi': 'https://doi.org/10.1021/jm060955d', 'mag': '1969041963', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17064063'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/jm060955d', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S162030435', 'display_name': 'Journal of Medicinal Chemistry', 'issn_l': '0022-2623', 'issn': ['0022-2623', '1520-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5104306642', 'display_name': 'Zhonghua Pei', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Zhonghua Pei', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064-6098, USA. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064-6098, USA. [email protected]', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100347683', 'display_name': 'Xiaofeng Li', 'orcid': 'https://orcid.org/0000-0002-2357-7940'}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Xiaofeng Li', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5067627069', 'display_name': 'Thomas W von Geldern', 'orcid': 'https://orcid.org/0000-0002-0649-7885'}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Thomas W. von Geldern', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016801798', 'display_name': 'David J. Madar', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David J. Madar', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078721849', 'display_name': 'Kenton L. Longenecker', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kenton Longenecker', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000329049', 'display_name': 'Hong Yong', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hong Yong', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053187750', 'display_name': 'Thomas Lübben', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Thomas H. Lubben', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012619985', 'display_name': 'Kent D. Stewart', 'orcid': 'https://orcid.org/0000-0001-6417-6927'}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kent D. Stewart', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007388418', 'display_name': 'Bradley A. Zinker', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bradley A. Zinker', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026441235', 'display_name': 'Bradley J. Backes', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bradley J. Backes', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5053404417', 'display_name': 'Andrew S. Judd', 'orcid': 'https://orcid.org/0000-0003-2562-8841'}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Andrew S. Judd', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052328037', 'display_name': 'Mathew M. Mulhern', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mathew Mulhern', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016954416', 'display_name': 'Stephen J. Ballaron', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Stephen J. Ballaron', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052113856', 'display_name': 'Michael A. Stashko', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael A. Stashko', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077385501', 'display_name': 'Amanda K. Mika', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Amanda K. Mika', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016246248', 'display_name': 'David W. A. Beno', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David W. A. Beno', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113527456', 'display_name': 'Glenn A. Reinhart', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Glenn A. Reinhart', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072528914', 'display_name': 'Ryan M. Fryer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ryan M. Fryer', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5017651263', 'display_name': 'Lee C. Preusser', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lee C. Preusser', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086306992', 'display_name': 'Anita J. Kempf-Grote', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Anita J. Kempf-Grote', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5109077288', 'display_name': 'Hing L. Sham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Hing L. Sham', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5084180043', 'display_name': 'James M. Trevillyan', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210142393', 'display_name': 'Abbott Fund', 'ror': 'https://ror.org/041w95745', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210142393']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James M. Trevillyan', 'raw_affiliation_strings': ['Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098'], 'affiliations': [{'raw_affiliation_string': 'Metabolic Disease Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064-6098', 'institution_ids': ['https://openalex.org/I4210142393']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.002, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 51, 'citation_normalized_percentile': {'value': 0.869578, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 93, 'max': 94}, 'biblio': {'volume': '49', 'issue': '22', 'first_page': '6439', 'last_page': '6442'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12505', 'display_name': 'Peptidase Inhibition and Analysis', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12505', 'display_name': 'Peptidase Inhibition and Analysis', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10401', 'display_name': 'Diabetes Treatment and Management', 'score': 0.9953, 'subfield': {'id': 'https://openalex.org/subfields/2712', 'display_name': 'Endocrinology, Diabetes and Metabolism'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10814', 'display_name': 'Neuropeptides and Animal Physiology', 'score': 0.9897, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/dipeptidyl-peptidase-4-inhibitor', 'display_name': 'Dipeptidyl peptidase-4 inhibitor', 'score': 0.5113201}, {'id': 'https://openalex.org/keywords/dipeptidyl-peptidase', 'display_name': 'Dipeptidyl peptidase', 'score': 0.50666267}, {'id': 'https://openalex.org/keywords/high-throughput-screening', 'display_name': 'High-Throughput Screening', 'score': 0.45190257}], 'concepts': [{'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.88706946}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.67501295}, {'id': 'https://openalex.org/C2776442012', 'wikidata': 'https://www.wikidata.org/wiki/Q2302144', 'display_name': 'Trifluoromethyl', 'level': 3, 'score': 0.6660468}, {'id': 'https://openalex.org/C156490143', 'wikidata': 'https://www.wikidata.org/wiki/Q412214', 'display_name': 'Dipeptidyl peptidase-4', 'level': 4, 'score': 0.6252551}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.6097402}, {'id': 'https://openalex.org/C181389837', 'wikidata': 'https://www.wikidata.org/wiki/Q461809', 'display_name': 'Bioavailability', 'level': 2, 'score': 0.5768053}, {'id': 'https://openalex.org/C2777180221', 'wikidata': 'https://www.wikidata.org/wiki/Q3025883', 'display_name': 'Type 2 diabetes', 'level': 3, 'score': 0.54615575}, {'id': 'https://openalex.org/C2778763485', 'wikidata': 'https://www.wikidata.org/wiki/Q419770', 'display_name': 'Dipeptidyl peptidase-4 inhibitor', 'level': 4, 'score': 0.5113201}, {'id': 'https://openalex.org/C2781469919', 'wikidata': 'https://www.wikidata.org/wiki/Q5279728', 'display_name': 'Dipeptidyl peptidase', 'level': 3, 'score': 0.50666267}, {'id': 'https://openalex.org/C51323132', 'wikidata': 'https://www.wikidata.org/wiki/Q626251', 'display_name': 'High-throughput screening', 'level': 2, 'score': 0.45190257}, {'id': 'https://openalex.org/C555293320', 'wikidata': 'https://www.wikidata.org/wiki/Q12206', 'display_name': 'Diabetes mellitus', 'level': 2, 'score': 0.43191457}, {'id': 'https://openalex.org/C74187038', 'wikidata': 'https://www.wikidata.org/wiki/Q1418791', 'display_name': 'Drug discovery', 'level': 2, 'score': 0.42442435}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.3327253}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.29883218}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.2727415}, {'id': 'https://openalex.org/C134018914', 'wikidata': 'https://www.wikidata.org/wiki/Q162606', 'display_name': 'Endocrinology', 'level': 1, 'score': 0.20944363}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.08837548}, {'id': 'https://openalex.org/C178790620', 'wikidata': 'https://www.wikidata.org/wiki/Q11351', 'display_name': 'Organic chemistry', 'level': 1, 'score': 0.07160491}, {'id': 'https://openalex.org/C2780263894', 'wikidata': 'https://www.wikidata.org/wiki/Q335268', 'display_name': 'Alkyl', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C150903083', 'wikidata': 'https://www.wikidata.org/wiki/Q7108', 'display_name': 'Biotechnology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D001713', 'descriptor_name': 'Biphenyl Compounds', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D018819', 'descriptor_name': 'Dipeptidyl Peptidase 4', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D015842', 'descriptor_name': 'Serine Proteinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001713', 'descriptor_name': 'Biphenyl Compounds', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': False}, {'descriptor_ui': 'D001713', 'descriptor_name': 'Biphenyl Compounds', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D001713', 'descriptor_name': 'Biphenyl Compounds', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D053138', 'descriptor_name': 'Cyclohexenes', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': False}, {'descriptor_ui': 'D053138', 'descriptor_name': 'Cyclohexenes', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D003924', 'descriptor_name': 'Diabetes Mellitus, Type 2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018819', 'descriptor_name': 'Dipeptidyl Peptidase 4', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015195', 'descriptor_name': 'Drug Design', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004353', 'descriptor_name': 'Drug Evaluation, Preclinical', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D007004', 'descriptor_name': 'Hypoglycemic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008958', 'descriptor_name': 'Models, Molecular', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011924', 'descriptor_name': 'Rats, Zucker', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015842', 'descriptor_name': 'Serine Proteinase Inhibitors', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': False}, {'descriptor_ui': 'D015842', 'descriptor_name': 'Serine Proteinase Inhibitors', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D015842', 'descriptor_name': 'Serine Proteinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013329', 'descriptor_name': 'Structure-Activity Relationship', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D014230', 'descriptor_name': 'Triazoles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014961', 'descriptor_name': 'X-Ray Diffraction', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1021/jm060955d', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S162030435', 'display_name': 'Journal of Medicinal Chemistry', 'issn_l': '0022-2623', 'issn': ['0022-2623', '1520-4804'], 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': True, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320006', 'host_organization_name': 'American Chemical Society', 'host_organization_lineage': ['https://openalex.org/P4310320006'], 'host_organization_lineage_names': ['American Chemical Society'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17064063', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_indexed_in_scopus': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.72, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 18, 'referenced_works': ['https://openalex.org/W1553821695', 'https://openalex.org/W1971244959', 'https://openalex.org/W1978953702', 'https://openalex.org/W1979916078', 'https://openalex.org/W1982227126', 'https://openalex.org/W1991565451', 'https://openalex.org/W1993287695', 'https://openalex.org/W1995621627', 'https://openalex.org/W2012437459', 'https://openalex.org/W2031468509', 'https://openalex.org/W2036167841', 'https://openalex.org/W2071817688', 'https://openalex.org/W2073996229', 'https://openalex.org/W2093303670', 'https://openalex.org/W2109157463', 'https://openalex.org/W2118609667', 'https://openalex.org/W2146232529', 'https://openalex.org/W2154615287'], 'related_works': ['https://openalex.org/W4231118168', 'https://openalex.org/W3029906047', 'https://openalex.org/W2586040949', 'https://openalex.org/W2460093818', 'https://openalex.org/W2153469285', 'https://openalex.org/W2059902547', 'https://openalex.org/W2030477680', 'https://openalex.org/W1971756125', 'https://openalex.org/W1602790973', 'https://openalex.org/W1483551457'], 'abstract_inverted_index': {'Dipeptidyl': [0], 'peptidase': [1], 'IV': [2], '(DPP4)': [3], 'deactivates': [4], 'glucose-regulating': [5], 'hormones': [6], 'such': [7], 'as': [8], 'GLP-1': [9], 'and': [10, 42, 68, 72], 'GIP,': [11], 'thus,': [12], 'DPP4': [13, 45], 'inhibition': [14], 'has': [15], 'become': [16], 'a': [17, 38, 63, 75], 'useful': [18], 'therapy': [19], 'for': [20, 79], 'type': [21, 83], '2': [22, 84], 'diabetes.': [23, 85], 'Optimization': [24], 'of': [25, 35, 65, 82], 'the': [26, 33, 80], 'high-throughput': [27], 'screening': [28], 'lead': [29], '6': [30], 'led': [31], 'to': [32], 'discovery': [34], '25': [36, 50, 59], '(ABT-341),': [37], 'highly': [39], 'potent,': [40], 'selective,': [41], 'orally': [43], 'bioavailable': [44], 'inhibitor.': [46], 'When': [47], 'dosed': [48], 'orally,': [49], 'dose-dependently': [51], 'reduced': [52], 'glucose': [53], 'excursion': [54], 'in': [55, 62, 66, 69], 'ZDF': [56], 'rats.': [57], 'Amide': [58], 'is': [60], 'safe': [61], 'battery': [64], 'vitro': [67], 'vivo': [70], 'tests': [71], 'may': [73], 'represent': [74], 'new': [76], 'therapeutic': [77], 'agent': [78], 'treatment': [81]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1969041963', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 4}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 1}, {'year': 2018, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 3}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 5}, {'year': 2012, 'cited_by_count': 5}], 'updated_date': '2025-01-21T09:04:44.742065', 'created_date': '2016-06-24'}